Aminopyridines: selective Aurora-A inhibitors

被引：8
作者：
Vianello, Paola [1 ]
机构：
[1] Nerviano Med Sci SRL, BU Oncol, I-20014 Nerivano, MI, Italy
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2007年 / 17卷 / 02期
关键词：
Aurora-A; Aurora-B; micosis;
D O I：
10.1517/13543776.17.2.255
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Aurora inhibitors have been extensively studied as potential novel anticancer agents. At least four compounds are now under clinical evaluation. Banyu discloses aminopyridines and -pyrazines acting as selective Aurora-A inhibitors. The claimed compounds demonstrated low nanomolar activity in the biochemical assay and exhibit a 200-fold specificity on Aurora-A versus Aurora-B.
引用
收藏
页码：255 / 261
页数：7
相关论文
共 50 条
  • [1] The role of Aurora-A inhibitors in cancer therapy
    Agnese, V.
    Bazan, V.
    Fiorentino, F. P.
    Fanale, D.
    Badalamenti, G.
    Colucci, G.
    Adamo, V.
    Santini, D.
    Russo, A.
    ANNALS OF ONCOLOGY, 2007, 18 : 47 - 52
  • [2] Computational approach to the identification of novel Aurora-A inhibitors
    Morshed, Mohammad Neaz
    Cho, Yong Seo
    Seo, Seon Hee
    Han, Ki-Cheol
    Yang, Eun Gyeong
    Pae, Ae Nim
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (02) : 907 - 916
  • [3] Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase
    Jung-Hyun Park
    Hyun-Soon Jong
    Sang Gyun Kim
    Yeonjoo Jung
    Keun-Wook Lee
    Ju-Hee Lee
    Dae-Kee Kim
    Yung-Jue Bang
    Tae-You Kim
    Journal of Molecular Medicine, 2008, 86 : 117 - 128
  • [4] Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase
    Park, Jung-Hyun
    Jong, Hyun-Soon
    Kim, Sang Gyun
    Jung, Yeonjoo
    Lee, Keun-Wook
    Lee, Ju-Hee
    Kim, Dae-Kee
    Bang, Yung-Jue
    Kim, Tae-You
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (01): : 117 - 128
  • [5] Drosophila Ajuba is not an Aurora-A activator but is required to maintain Aurora-A at the centrosome
    Sabino, Dora
    Brown, Nicholas H.
    Basto, Renata
    JOURNAL OF CELL SCIENCE, 2011, 124 (07) : 1156 - 1166
  • [6] Progress in the development of selective inhibitors of Aurora kinases
    Mortlock, A
    Keen, NJ
    Jung, FH
    Heron, NM
    Foote, KM
    Wilkinson, R
    Green, S
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 199 - 213
  • [7] Pharmacophore modelling and virtual screening for identification of new aurora-a kinase inhibitors
    Deng, Xiao-Qiang
    Wang, Hui-Yuan
    Zhao, Ying-Lan
    Xiang, Ming-Li
    Jiang, Pei-Du
    Cao, Zhi-Xing
    Zheng, Yu-Zhu
    Luo, Shi-Dong
    Yu, Luo-Ting
    Wei, Yu-Quan
    Yang, Sheng-Yong
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (06) : 533 - 539
  • [8] Identification of Aurora-A Inhibitors by Ligand and Structure-Based Virtual Screening
    Morshed, Mohammad Neaz
    MOLECULAR INFORMATICS, 2014, 33 (05) : 369 - 381
  • [9] Structure-based design of imidazo[1,2-a] pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells
    Bouloc, Nathalie
    Large, Jonathan M.
    Kosmopoulou, Magda
    Sun, Chongbo
    Faisal, Amir
    Matteucci, Mizio
    Reynisson, Johannes
    Brown, Nathan
    Atrash, Butrus
    Blagg, Julian
    McDonald, Edward
    Linardopoulos, Spiros
    Bayliss, Richard
    Bavetsias, Vassilios
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (20) : 5988 - 5993
  • [10] Physiological and Oncogenic Aurora-A Pathway
    Saeki, Toshiaki
    Ouchi, Mutsuko
    Ouchi, Toru
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2009, 5 (07): : 722 - 726
12345